{
    "Trade/Device Name(s)": [
        "ADVIA 2120 with nRBC Method",
        "ADVIA 2120 Hematology Analyzer with Autoslide"
    ],
    "Submitter Information": "Bayer HealthCare LLC",
    "510(k) Number": "K051693",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042251"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKL",
        "GKZ",
        "KPA"
    ],
    "Summary Letter Date": "December 7, 2005",
    "Summary Letter Received Date": "October 27, 2005",
    "Submission Date": "October 26, 2005",
    "Regulation Number(s)": [
        "21CFR864.5200",
        "21CFR864.5220",
        "21CFR864.3800"
    ],
    "Regulation Name(s)": [
        "Automated cell counter",
        "Differential cell counter",
        "Automated slide stainer"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Nucleated red blood cells"
    ],
    "Specimen Type(s)": [
        "Peripheral whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA 2120 Hematology Analyzer with Autoslide"
    ],
    "Method(s)/Technology(ies)": [
        "Histogram analysis",
        "Arithmetic algorithm",
        "Cytogram analysis"
    ],
    "Methodologies": [
        "Quantitative cell counting",
        "Correction algorithm for WBC count"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Automated system",
        "Method",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA 2120 Hematology Analyzer with Autoslide and nRBC method for automated nucleated red blood cell quantitation and WBC correction in peripheral whole blood.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of nucleated red blood cells in peripheral whole blood.",
    "fda_folder": "Hematology"
}